Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: A review

Pathobiology

Volumn 77, Issue 4, 2010, Pages 169-180

  Horny, H P ^a   Sotlar, K ^b   Valent, P ^c  

^a Institute of Pathology Ansbach   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone marrow; Mast cell leukemia; Mastocytosis; Systemic mastocytosis

Indexed keywords

CD30 ANTIGEN;

BONE MARROW BIOPSY; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIC LEUKEMIA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MAJOR CLINICAL STUDY; MAST CELL LEUKEMIA; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW; SYSTEMIC MASTOCYTOSIS; ADULT; BASOPHIL; BIOPSY; BONE MARROW; GENETICS; IMMUNOLOGY; MAST CELL; MASTOCYTOSIS, SYSTEMIC; MYELOPROLIFERATIVE DISORDERS; PATHOLOGY; POINT MUTATION; URTICARIA PIGMENTOSA;

ADULT; BASOPHILS; BIOPSY; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MYELOPROLIFERATIVE DISORDERS; POINT MUTATION; URTICARIA PIGMENTOSA;

EID: 77954508689     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000305552     Document Type: Review

References (24)

1. Valent P, Horny H-P, Escribano L, et al: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference Report of 'Year 2000 Working Conference on Mastocytosis'. Leuk Res 2001; 25: 603-625.
2. Horny HP, Valent P: Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001; 25: 543-551.
3. Horny HP, Metcalfe DD, Bennett J, Bain BJ, Akin C, Escribano L, Valent P: Mastocytosis: World Health Organization (WHO) Classification of Tumours. Pathology and Genetics; in Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): Tumours of Haematopoietic and Lymphoid Tissues. Geneva, WHO, 2008, vol 1.
4. Horny HP, Valent P: Histopathological and immunophenotypical aspects of mastocytosis. Int Arch Allergy Immunol 2002; 127: 115-117.
5. Horny HP, Sotlar K, Stellmacher F, Krokowski M, Agis H, Schwartz LB, Valent P: The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-bm): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006; 59: 298-302.
6. Sotlar K, Horny HP, Simonitsch I, Krokowski M, Aichberger KJ, Mayerhofer M, Printz D, Fritsch G, Valent P: CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004; 28: 1319-1325.
7. Maric I, Robyn J, Metcalfe DD, Fay MP, Carter M, Wilson T, Fu W, Stoddard J, Scott L, Hartsell M, Kirshenbaum A, Akin C, Nutman TB, Noel P, Klion AD: KITD816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol 2007; 120: 680-687.
8. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD: A novel form of mastocytosis with a transmembrane c-kit mutation and response to imatinib. Blood 2004; 103: 3222-3225.
9. Horny H-P, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, et al: Diagnostic utility of staining for tryptase in patients with mastocytosis. Am J Surg Pathol, 1998; 22: 1132-1140.
10. Sotlar K, Saeger W, Stellmacher F, Stahmer J, Jäckle S, Valent P, Horny H-P: 'Occult' mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis. J Clin Pathol 2006; 59: 875-878.
11. Caplan RM: The natural course of urticaria pigmentosa. Arch Dermatol 1963; 87: 146-157.
12. Horny HP, Sotlar K, Stellmacher F, Valent P, Grabbe J: An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). J Clin Pathol 2006; 59: 264-268.
13. Valent P, Akin C, Sperr WR, Escribano L, Arock M, Horny HP, Bennett JM, Metcalfe DD: Aggressive systemic mastocytosis and related mast cell disorders: current treament options and proposed response criteria. Leuk Res 2003; 27: 635-641.
14. Travis WD, Li CY, Hogaland HC, Travis LB, Banks PM: Mast cell leukemia: Report of a case and review of the literature. Mayo Clin Proc 1986; 61: 957-966.
15. Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP, Valent P: Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001; 25: 529-536.
16. Valent P, Samorapoompichit P, Sperr WR, Horny HP, Lechner K: Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. The Hematology Journal 2002; 3: 90-94.
17. Gauer A, Hagen V, Merz H: A new sarcomatoid variant of multiple myeloma in a 20 year-old male. Ann Hematol 2004; 83: 251-252.
18. Valent P, Sperr WR, Samorapoompichit P, Geissler K, Lechner K, Horny HP, Bennett JM: Myelomastocytic overlap syndromes: Biology, criteria, and relationship to mastocytosis. Leuk Res 2001; 25: 595-602.
19. Horny HP, Sotlar K, Sperr WR, Valent P: Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 2004; 57: 604-608.
20. Sperr WR, Horny HP, Lechner K, Valent P: Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma 2000; 37: 473-486.
21. Bernd HW, Sotlar K, Lorenzen J, Osieka R, Fabry U, Valent P, Horny HP: Acute myeloid leukemia with t(8; 21) associated with 'occult' mastocytosis: report of an unusual case and review of the literature. J Clin Pathol 2004; 57: 324-328.
22. Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM, et al: CHIC2 deletion, a surrogate for FIP1L1- PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 2003; 102: 3093-3096.
23. Sotlar K, Colak S, Bache A. Berezowska S, Krokowski M, Bültmann B, Valent P, Horny H-P: Variable presence of KIT(D816V) in clonal haematological non-mast cell diseases associated with systemic mastocytosis (SMAHNM). J Pathol 2010; 220: 586-595.
24. Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP: Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008; 10: 58-66.